196 related articles for article (PubMed ID: 32471474)
41. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
[No Abstract] [Full Text] [Related]
42. Effects on the transcriptome upon deletion of a distal element cannot be predicted by the size of the H3K27Ac peak in human cells.
Tak YG; Hung Y; Yao L; Grimmer MR; Do A; Bhakta MS; O'Geen H; Segal DJ; Farnham PJ
Nucleic Acids Res; 2016 May; 44(9):4123-33. PubMed ID: 26743005
[TBL] [Abstract][Full Text] [Related]
43. KMT2C mutation as a predictor of immunotherapeutic efficacy in colorectal cancer.
Ni C; Wang X; Liu S; Zhang J; Luo Z; Xu B
Sci Rep; 2024 Apr; 14(1):8284. PubMed ID: 38594266
[TBL] [Abstract][Full Text] [Related]
44. Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers.
Yan J; Chen SA; Local A; Liu T; Qiu Y; Dorighi KM; Preissl S; Rivera CM; Wang C; Ye Z; Ge K; Hu M; Wysocka J; Ren B
Cell Res; 2018 Feb; 28(2):204-220. PubMed ID: 29313530
[TBL] [Abstract][Full Text] [Related]
45. Loss of MLL3/4 decouples enhancer H3K4 monomethylation, H3K27 acetylation, and gene activation during embryonic stem cell differentiation.
Boileau RM; Chen KX; Blelloch R
Genome Biol; 2023 Mar; 24(1):41. PubMed ID: 36869380
[TBL] [Abstract][Full Text] [Related]
46. Identification of ZBTB18 as a novel colorectal tumor suppressor gene through genome-wide promoter hypermethylation analysis.
Bazzocco S; Dopeso H; Martínez-Barriocanal Á; Anguita E; Nieto R; Li J; García-Vidal E; Maggio V; Rodrigues P; de Marcondes PG; Schwartz S; Aaltonen LA; Sánchez A; Mariadason JM; Arango D
Clin Epigenetics; 2021 Apr; 13(1):88. PubMed ID: 33892786
[TBL] [Abstract][Full Text] [Related]
47. Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway.
Chen Z; Wang C; Dong H; Wang X; Gao F; Zhang S; Zhang X
Mol Med; 2020 Jan; 26(1):14. PubMed ID: 32000660
[TBL] [Abstract][Full Text] [Related]
48. Genome-wide screening for methylation-silenced genes in colorectal cancer.
Khamas A; Ishikawa T; Mogushi K; Iida S; Ishiguro M; Tanaka H; Uetake H; Sugihara K
Int J Oncol; 2012 Aug; 41(2):490-6. PubMed ID: 22664866
[TBL] [Abstract][Full Text] [Related]
49. UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells.
Niinuma T; Kitajima H; Kai M; Yamamoto E; Yorozu A; Ishiguro K; Sasaki H; Sudo G; Toyota M; Hatahira T; Maruyama R; Tokino T; Nakase H; Sugai T; Suzuki H
Clin Epigenetics; 2019 May; 11(1):70. PubMed ID: 31064417
[TBL] [Abstract][Full Text] [Related]
50. Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition.
Wang C; Lee JE; Lai B; Macfarlan TS; Xu S; Zhuang L; Liu C; Peng W; Ge K
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11871-11876. PubMed ID: 27698142
[TBL] [Abstract][Full Text] [Related]
51. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
[TBL] [Abstract][Full Text] [Related]
52. Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin.
Jung BH; Beck SE; Cabral J; Chau E; Cabrera BL; Fiorino A; Smith EJ; Bocanegra M; Carethers JM
Gastroenterology; 2007 Feb; 132(2):633-44. PubMed ID: 17258738
[TBL] [Abstract][Full Text] [Related]
53. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H
Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123
[TBL] [Abstract][Full Text] [Related]
54. MLL3 suppresses tumorigenesis through regulating TNS3 enhancer activity.
Zheng JY; Wang CY; Gao C; Xiao Q; Huang CW; Wu M; Li LY
Cell Death Dis; 2021 Apr; 12(4):364. PubMed ID: 33824309
[TBL] [Abstract][Full Text] [Related]
55. Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer.
Suzuki H; Takatsuka S; Akashi H; Yamamoto E; Nojima M; Maruyama R; Kai M; Yamano HO; Sasaki Y; Tokino T; Shinomura Y; Imai K; Toyota M
Cancer Res; 2011 Sep; 71(17):5646-58. PubMed ID: 21734013
[TBL] [Abstract][Full Text] [Related]
56. Methylation of
Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M
Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151
[TBL] [Abstract][Full Text] [Related]
57. Frameshift mutation of a histone methylation-related gene SETD1B and its regional heterogeneity in gastric and colorectal cancers with high microsatellite instability.
Choi YJ; Oh HR; Choi MR; Gwak M; An CH; Chung YJ; Yoo NJ; Lee SH
Hum Pathol; 2014 Aug; 45(8):1674-81. PubMed ID: 24925220
[TBL] [Abstract][Full Text] [Related]
58. Allele-specific DNA methylation reinforces PEAR1 enhancer activity.
Izzi B; Pistoni M; Cludts K; Akkor P; Lambrechts D; Verfaillie C; Verhamme P; Freson K; Hoylaerts MF
Blood; 2016 Aug; 128(7):1003-12. PubMed ID: 27313330
[TBL] [Abstract][Full Text] [Related]
59. RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis.
Bond CE; McKeone DM; Kalimutho M; Bettington ML; Pearson SA; Dumenil TD; Wockner LF; Burge M; Leggett BA; Whitehall VL
Oncotarget; 2016 Oct; 7(43):70589-70600. PubMed ID: 27661107
[TBL] [Abstract][Full Text] [Related]
60. Differential expression of CD133 based on microsatellite instability status in human colorectal cancer.
Park JJ; Kwon JH; Oh SH; Choi J; Moon CM; Ahn JB; Hong SP; Cheon JH; Kim TI; Kim H; Kim WH
Mol Carcinog; 2014 Feb; 53 Suppl 1():E1-10. PubMed ID: 23065858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]